Ristocetin

Europe	+32 16 58 90 45	+32 16 50 90 45
France	01 43 25 01 50	01 43 25 01 60
Italy	02 36 00 65 930	02 36 00 65 94
Germany	0241 6085 13140	0241 6085 33033
Japan	+81 78 386 0860	+81 78 306 0296

[ Promotions ] [ GENTAUR Products ] [ Distributed Products ] [ Equipment ] [ Custom service ] [ Complete Pricelist ]

info@gentaur.com RistocetinRistocetinRistocetinRistocetinRistocetinRistocetinRistocetinRistocetinRistocetin

GENTAUR EUROPE

+32 1658 9045
+32 1650 9045

BELGIUM

tel +32 2 732 5688
fax +32 2 732 4414
fax +32 2 732 4414
info@gentaur.com
Av. de l' Armée 68
B-1040 Brussels

France

tel 01 43 25 01 50
fax01 43 25 01 60
9, rue Lagrange
75005 Paris

Italy

tel 02 36 00 65 93
fax 02 36 00 65 94
20135 Milano

Germany

tel +49 241 6085 13140
fax +49 241 6085 33033
Forckenbeckstraße 6
D-52074 Aachen

Japan

tel +81 78 386 0860
fax +81 78 306 0296
Minaatojimaminami-manchi
Chuo-ku, Kobe
065-0047

100 mg : 375 Euro

6 x 100 mg : 1985 Euro

1 g : 2250 Euro

Using Ristocetin to Diagnose von Willebrand's Disease

In an unexplained way RISTOCETIN, a glycopeptide antibiotic isolated from Norcadia lurida, initiates binding of VWF to platelet glycoprotein Ib. Although the mechanism is not fully understood, RISTOCETIN has been widely used for IN VITRO testing of VWF function.

Two Ristocetin associated assays exist:

RISTOCETIN COFACTOR ACTIVITY - This assay is important in the diagnosis of VWD. It determines the plasma VWF dependent agglutination using a standardized platelet preparation of either freeze-dried platelets or platelets fixed with formalin or para-formaldehyde.

RIPA - Another methodology, named the Ristocetin Induced Platelet Agglutination (RIPA), is an overall assay of the Ristocetin induced agglutination of the patient's own platelets and plasma. The major advantage of this test is in the detection of VWD cases with a hyper aggregation tendency. In addition, it serves in the diagnosis of platelet dysfunction due to deficiency of platelet surface glycoprotein Ib (Bernard-Soulier syndrome).

TESTING FOR VWD TODAY - IS ENOUGH BEING DONE?

A usual coagulation screen will probably include:

Platelet Count
Bleeding TIme
PTT

For VWD patients, these screens are not sufficient!

In VWD, the platelet count could be normal, and the bleeding time and PTT could also be normal due to external factors such as stress or exercise temporarily elevating the factor VIII levels.

The solution is to use RISTOCETIN

If identifying sufferers from VWD is important, at least one of the Ristocetin based assays should be included as part of the initial screen for patients with any indications of a potential bleeding disorder and also as part of any pre-surgical bloodwork.

Use RISTOCETIN

When there is...

prolonged bleeding.
reduced factor VIII activity.
impaired platelet function.
a genetic history but no evidence of hemophilia.

To differentiate the types of VWD.

In pre- and post-surgery.

In the differential diagnosis of hemophiliacs.

On all new borns

Send mail to webmaster@gentaur.com with questions or comments about this web site. Copyright © 2008 Gentaur Molecular Products Site powered by Acid Dragon (AC) Last modified: 07/15/09

Send mail to webmaster@gentaur.com with questions or comments about this web site.
Copyright © 2008 Gentaur Molecular Products
Site powered by Acid Dragon (AC)
Last modified: 07/15/09